United States · FDA National Drug Code directory
Cetirizine Hydrochloride Tablets, 5 mg
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25000-219_172d56b9-ba90-4e1b-934a-f75307564ea3
- Product NDC
- 25000-219
- Form
- TABLET
- Composition / generic term
- Cetirizine Hydrochloride
- Labeler
- MARKSANS PHARMA LIMITED
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220113
- Source listing expiry
- 20271231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (25000-219-03) / 30 TABLET in 1 BOTTLE · 25000-219-03
- 1 BOTTLE in 1 CARTON (25000-219-08) / 100 TABLET in 1 BOTTLE · 25000-219-08
- 1000 TABLET in 1 BOTTLE (25000-219-14) · 25000-219-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →